Aberdeen Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-278,528
| Closed | -$2.1M | – | 917 |
|
|
2023
Q1 | $2.1M | Sell |
278,528
-5,735
| -2% | -$43.2K | 0.01% | 716 |
|
|
2022
Q4 | $2.88M | Buy |
284,263
+8,831
| +3% | +$89.5K | 0.01% | 652 |
|
|
2022
Q3 | $2.72M | Sell |
275,432
-99,630
| -27% | -$985K | 0.01% | 652 |
|
|
2022
Q2 | $3.92M | Sell |
375,062
-35,390
| -9% | -$370K | 0.01% | 600 |
|
|
2022
Q1 | $4M | Sell |
410,452
-59,826
| -13% | -$583K | 0.01% | 632 |
|
|
2021
Q4 | $6.73M | Buy |
470,278
+44,400
| +10% | +$635K | 0.01% | 581 |
|
|
2021
Q3 | $8.45M | Buy |
425,878
+125,450
| +42% | +$2.49M | 0.02% | 530 |
|
|
2021
Q2 | $6.61M | Buy |
300,428
+120,300
| +67% | +$2.65M | 0.01% | 585 |
|
|
2021
Q1 | $6.19M | Buy |
+180,128
| New | +$6.19M | 0.01% | 596 |
|